MX347190B - Proceso para produccion de fibrinogeno. - Google Patents

Proceso para produccion de fibrinogeno.

Info

Publication number
MX347190B
MX347190B MX2013002657A MX2013002657A MX347190B MX 347190 B MX347190 B MX 347190B MX 2013002657 A MX2013002657 A MX 2013002657A MX 2013002657 A MX2013002657 A MX 2013002657A MX 347190 B MX347190 B MX 347190B
Authority
MX
Mexico
Prior art keywords
fibrinogen
production
amion
fibrinopeptide
prion
Prior art date
Application number
MX2013002657A
Other languages
English (en)
Other versions
MX2013002657A (es
Inventor
Schulz Petra
Pape Rainer
Gehringer Werner
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of MX2013002657A publication Critical patent/MX2013002657A/es
Publication of MX347190B publication Critical patent/MX347190B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un método o proceso para la fabricación de concentrado de fibrinógeno nativo que ahorra virus y prion de alta pureza y bajas cantidades de fibrinopéptido A y fibronectina, cuyo método comprende la etapa cromatografía en un anión fuerte injertado con grupos amino terciarios o cuaternarios.
MX2013002657A 2010-09-20 2011-09-20 Proceso para produccion de fibrinogeno. MX347190B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10177640 2010-09-20
US34471910P 2010-09-21 2010-09-21
PCT/EP2011/066293 WO2012038410A1 (en) 2010-09-20 2011-09-20 Process for production of fibrinogen

Publications (2)

Publication Number Publication Date
MX2013002657A MX2013002657A (es) 2013-04-08
MX347190B true MX347190B (es) 2017-04-19

Family

ID=43048945

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002657A MX347190B (es) 2010-09-20 2011-09-20 Proceso para produccion de fibrinogeno.

Country Status (11)

Country Link
US (2) US9371355B2 (es)
EP (1) EP2619225B1 (es)
JP (1) JP2013537215A (es)
KR (1) KR20130112031A (es)
CN (2) CN106046147B (es)
AU (1) AU2011304364B2 (es)
CA (1) CA2809471A1 (es)
ES (1) ES2586698T3 (es)
MX (1) MX347190B (es)
RU (1) RU2603103C2 (es)
WO (1) WO2012038410A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809471A1 (en) * 2010-09-20 2012-03-29 Octapharma Ag Process for production of fibrinogen
US10112972B2 (en) 2012-03-13 2018-10-30 Octapharma Ag Process for production of fibrinogen and fibrinogen produced thereby
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
RU2556804C2 (ru) * 2013-12-17 2015-07-20 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата фибриногена
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
US10799533B2 (en) * 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
CN107540743A (zh) * 2017-10-11 2018-01-05 南岳生物制药有限公司 一种双层析法制备人纤维蛋白原的方法
KR20220113430A (ko) * 2019-12-10 2022-08-12 바이오테스트 아게 피브리노겐 제제의 제조 방법
CN117794516A (zh) 2021-08-13 2024-03-29 生物测试股份公司 纤维蛋白原组合物和制备方法
CN113698470B (zh) * 2021-09-02 2023-03-17 成都蓉生药业有限责任公司 一种人纤维蛋白原的纯化方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
DE69530914T2 (de) 1994-02-17 2004-03-11 New York Blood Center, Inc. Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung
US5834420A (en) * 1994-07-14 1998-11-10 Croix-Rouge De Belgique Fibrinogen concentrate obtained from blood plasma, process and plant for its preparation
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
US7572769B2 (en) 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
DE60027695T2 (de) * 1999-02-12 2007-04-26 Baxter Ag Verfahren zur herstellung von fibrinogen und fibronectin sowie proteinzusammesetzungen, welche damit herstellbar sind
JP4660048B2 (ja) * 1999-12-23 2011-03-30 シーエスエル、リミテッド 血漿プロテアーゼからのフィブリノゲンの分離
EP1148063A1 (de) 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
IL136552A (en) * 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
CA2447789C (en) * 2001-05-21 2012-11-06 Omrix Biopharmaceuticals S.A. Removal of plasminogen or plasmin from protein solutions
DE10211632A1 (de) 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
AT501088A2 (de) 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
ES2214967B1 (es) 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US7968682B2 (en) 2006-12-12 2011-06-28 Oregon Health & Science University Degradation-resistant fibrinogen sealants
US8741846B2 (en) 2008-06-23 2014-06-03 Bio-Products & Bio-Engineering Ag Storage-stable, functionally intact fibrinogen
CN101703763B (zh) * 2009-11-05 2012-07-11 绿十字(中国)生物制品有限公司 人纤维蛋白原的生产方法
CA2809471A1 (en) 2010-09-20 2012-03-29 Octapharma Ag Process for production of fibrinogen
US10112972B2 (en) 2012-03-13 2018-10-30 Octapharma Ag Process for production of fibrinogen and fibrinogen produced thereby

Also Published As

Publication number Publication date
MX2013002657A (es) 2013-04-08
AU2011304364B2 (en) 2015-07-09
CN106046147A (zh) 2016-10-26
BR112013006384A2 (pt) 2017-07-18
RU2603103C2 (ru) 2016-11-20
US9371355B2 (en) 2016-06-21
WO2012038410A1 (en) 2012-03-29
KR20130112031A (ko) 2013-10-11
US9938318B2 (en) 2018-04-10
AU2011304364A1 (en) 2013-01-31
CN106046147B (zh) 2019-11-19
CN103328503B (zh) 2016-08-24
EP2619225A1 (en) 2013-07-31
CN103328503A (zh) 2013-09-25
RU2013118323A (ru) 2014-10-27
EP2619225B1 (en) 2016-06-15
US20130274444A1 (en) 2013-10-17
US20160264619A1 (en) 2016-09-15
ES2586698T3 (es) 2016-10-18
CA2809471A1 (en) 2012-03-29
JP2013537215A (ja) 2013-09-30

Similar Documents

Publication Publication Date Title
MX2013002657A (es) Proceso para la produccion de fibrinogeno.
SG162687A1 (en) Caustic stable chromatography ligands
WO2011139646A3 (en) Method for producing tetrafluoropropenes
MX2007011668A (es) Mezclas de caucho de silicona de reticulacion por adicion autoadhesivas, metodo para la produccion de las mismas, metodo para producir partes moldeadas compuestas y uso de las mismas.
WO2014178078A3 (en) Novel cloning, expression & purification method for the preparation of ranibizumab
MY181068A (en) Recombinant microorganism for improved production of fine chemicals
UA105785C2 (uk) Спосіб очищення ліпопептидів
PH12016501094A1 (en) Recombinant microorganism for improved production of fine chemicals
PH12017502215A1 (en) Recombinant microorganism for improve production of fine chemicals
NZ742745A (en) Variants of chymosin with improved milk-clotting properties
MY189932A (en) Recombinant microorganism for improved production of alanine
WO2014017493A9 (ja) ワクチン
WO2011120690A3 (en) Separation of insoluble target proteins
UA115542C2 (uk) Процес синтезу терапевтичних пептидів
PH12018500150A1 (en) Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them
MY180633A (en) Solid particles, containing lactam, activator, and catalyst, method for producing said solid particles, and use of said solid particles
MX362689B (es) Procedimiento de preparacion de derivados de acido 3,5-bis(fluoroalquil)pirazol-4-carboxilico y 3,5-bis(fluoroalquil) pirazoles.
HK1163659A1 (en) Process for the preparation of ajoene
EA200900984A1 (ru) Улучшение клеточного роста
WO2014044626A3 (en) Process for producing gelatin employing aspergillopepsin ii
MX2019012022A (es) Produccion en alta pureza de proteinas milti-subunitarias tales como anticuerpos en microbios transformados tal como pichia pastoris.
WO2013092672A3 (en) Method for recombinant production of labyrinthopeptins and functional derivatives thereof
WO2012107445A3 (en) Soft substrate for cell culture and process for preparing the same
IN2013MU02726A (es)
WO2012107451A3 (en) Method to screen compounds influencing plant cell growth and production

Legal Events

Date Code Title Description
FG Grant or registration